1610454-64-2

Upstream product

• 1610455-09-8 4,5-dichloro-2-(3-methoxypropyl)aniline 
• 1610455-11-2 1,2-dichloro-4-(3-methoxypropyl)-5-nitrobenzene 
• 1610455-10-1 1,2-dichloro-4-(3-methoxypropyl)benzene 
• 39960-05-9 3-(3 ,4-dichlorophenyl)propan-1-ol 
• 25173-68-6 3(3,4-dichlorophenyl)propanoic acid 
• 1610455-13-4 1,2-dichloro-4-isocyanato-5-(3-methoxypropyl)benzene 
• 1610454-96-0 4-methyl-3-(1-methylpiperidin-4-yl)-1-phenyl-1H-pyrazol-5-amine 
• 1610418-21-7 tert-butyl 4-(5-amino-4-methyl-1-phenyl-1H-pyrazol-3-yl)piperidine-1-carboxylate 
• 1610454-97-1 tert-butyl 4-(2-cyanopropanoyl)piperidine-1-carboxylate 
• 142851-03-4 1-tert-butyl 4-ethyl piperidine-1,4-dicarboxylate 

Relevant academic research and scientific papers

N-(MONOCYCLIC ARYL),N'-PYRAZOLYL-UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS

Compounds of Formula (I) or stereoisomers, tautomers, or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ring A, Ring C and X are as defined herein, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation/inflammatory diseases, neurodegenerative diseases, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis or pelvic pain syndrome.